Exelixis
EXEL
#1768
Rank
A$17.67 B
Marketcap
A$65.64
Share price
0.05%
Change (1 day)
14.45%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company